Genor Biopharma Holdings Ltd operates as a biopharmaceutical company. The Company focuses on developing and commercializing oncology and autoimmune drugs. Genor Biopharma Holdings serves customers worldwide.

Next Day Disclosure Return

(Revised) Next Day Disclosure Return

Announcements and Notices - [Very Substantial Acquisition / Issue of Shares under a Specific Mandate / Consideration Issue / Reverse Takeover / Announcement by Offeree Company under the Takeovers Code / Connected Transaction / Change of Company Name / Capital Reorganisation / Share Scheme / Delay in Dispatch of Circular or other Document]

Delay In Despatch Of The Circular In Relation To - (1) Very Substantial Acquisition Involving Issue Of Consideration Shares Under Specific Mandate; (2) Reverse Takeover Involving The New Listing Application; (3) Application For Whitewash Waiver; (4) Special Deal; (5) Proposed Change Of Company Name; (6) Proposed Increase In Authorised Share Capital Of The Company; And (7) Proposed Adoption Of The One-Off Share Option Plan

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Genor Biopharma Holdings (6998 HK)

Next Day Disclosure Return

(Revised) Next Day Disclosure Return

Next Day Disclosure Return

Exchange Notice - Resumption Of Trading

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)